Table 4.
Distribution of facility payout scores by other subgroups of facilities
| Facility subgroups | By payment cycle |
Pooled average cycles | ||||||
|---|---|---|---|---|---|---|---|---|
| Cycle 1 | Cycle 2 | Cycle 3 | Cycle 4 | Cycle 5 | Cycle 6 | Cycle 7 | Cycles 1–7 | |
| Facility location | ||||||||
| Rural (%) | 52.2 | 48.5 | 66.3 | 69.5 | 76.4 | 71.3 | 80.0 | 66.4 |
| Urban (%) | 42.3 | 56.7 | 58.3 | 60.1 | 68.1 | 63.2 | 68.9 | 59.7 |
| Gap (%) | 9.9** | –8.2* | 8.0 | 9.4* | 8.3 | 8.1 | 11.1** | 6.7* |
| Ratio | 1.2 | 0.9 | 1.1 | 1.2 | 1.1 | 1.1 | 1.2 | 1.1 |
| Ownership status | ||||||||
| Public owned (%) | 49.9 | 49.5 | 66.0 | 68.8 | 75.8 | 70.0 | 78.4 | 65.6 |
| Non-public (%) | 50.9 | 54.4 | 56.9 | 60.6 | 66.7 | 67.1 | 73.6 | 61.5 |
| Gap (%) | –1.0 | –4.9 | 9.1 | 8.2 | 9.1 | 2.9 | 4.8 | 4.1 |
| Ratio | 1.0 | 0.9 | 1.2 | 1.1 | 1.1 | 1.0 | 1.1 | 1.1 |
| Level of care | ||||||||
| Dispensary (%) | 47.7 | 46.9 | 60.2 | 63.5 | 71.5 | 66.9 | 75.4 | 61.9 |
| HC and hospital (%) | 55.8 | 58.3 | 75.3 | 77.0 | 81.7 | 75.8 | 82.9 | 72.4 |
| Gap (%) | −8.1* | −11.4** | −15.1*** | −13.5*** | −10.2*** | −8.9** | −7.5** | −10.5*** |
| Ratio | 0.9 | 0.8 | 0.8 | 0.8 | 0.9 | 0.9 | 0.9 | 0.9 |
| Electricity and water supply | ||||||||
| Available (%) | 53.6 | 51.9 | 66.7 | 69.1 | 76.8 | 71.3 | 81.1 | 67.2 |
| None (%) | 45.9 | 48.3 | 62.1 | 65.5 | 71.7 | 67.5 | 73.5 | 62.2 |
| Gap (%) | 7.7* | 3.6 | 4.6 | 3.6 | 5.1 | 3.8 | 7.6** | 5.0* |
| Ratio | 1.2 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 |
| Availability of drugs | ||||||||
| Above the median (%) | 50.6 | 58.6 | 68.3 | 72.2 | 76.0 | 74.6 | 79.3 | 68.5 |
| Below the median (%) | 49.7 | 41.8 | 61.0 | 62.9 | 73.2 | 64.6 | 76.0 | 61.5 |
| Gap (%) | 0.9 | 16.8*** | 7.3* | 9.3** | 2.8 | 10.0** | 3.3 | 7.0*** |
| Ratio | 1.0 | 1.4 | 1.1 | 1.1 | 1.0 | 1.2 | 1.0 | 1.1 |
Analysis restricted to intervention facilities only (n = 75); Gap is the difference in payout score between two subgroups of facilities; ratio is the ratio of payout scores for two subgroups; the significance test was by t-test for the null hypothesis of gap equals zero; the results were generally similar when non-parametric test (Wilcoxon rank-sum) was used to test the significant of the gap (results not shown).
*
Significance at 10% level.
**
Significance at 5% level.
***
Significance at 1% level.